These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15994564)

  • 1. The role of proteomics in investigating psychiatric disorders.
    Pennington K; Cotter D; Dunn MJ
    Br J Psychiatry; 2005 Jul; 187():4-6. PubMed ID: 15994564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative proteomics for investigating psychiatric disorders.
    Filiou MD; Turck CW; Martins-de-Souza D
    Proteomics Clin Appl; 2011 Feb; 5(1-2):38-49. PubMed ID: 21280236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technological advances for deciphering the complexity of psychiatric disorders: merging proteomics with cell biology.
    Wesseling H; Guest PC; Lago SG; Bahn S
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1327-41. PubMed ID: 24524332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic biomarkers for psychiatric disorders: a progress update.
    Martins-de-Souza D; Turck CW
    Biomark Med; 2012 Apr; 6(2):189-92. PubMed ID: 22448792
    [No Abstract]   [Full Text] [Related]  

  • 5. A Protocol for Generation of a Corticosterone Model of Psychiatric Disorders.
    Guest PC
    Adv Exp Med Biol; 2017; 974():263-268. PubMed ID: 28353245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic Studies of Psychiatric Disorders.
    Guest PC
    Methods Mol Biol; 2018; 1735():59-89. PubMed ID: 29380307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Proteomic Approaches to Accelerate Drug Development for Psychiatric Disorders.
    Rahmoune H; Martins-de-Souza D; Guest PC
    Adv Exp Med Biol; 2017; 974():69-84. PubMed ID: 28353225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of the variation of mouse brain proteome by two-dimensional electrophoresis.
    Földi I; Müller G; Penke B; Janáky T
    J Proteomics; 2011 May; 74(6):894-901. PubMed ID: 21406261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining redox-proteomics and epigenomics to explain the involvement of oxidative stress in psychiatric disorders.
    Andreazza AC
    Mol Biosyst; 2012 Oct; 8(10):2503-12. PubMed ID: 22710408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can proteomics-based diagnostics aid clinical psychiatry?
    Filiou MD
    Proteomics Clin Appl; 2015 Oct; 9(9-10):885-8. PubMed ID: 25619150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric disorders biochemical pathways unraveled by human brain proteomics.
    Saia-Cereda VM; Cassoli JS; Martins-de-Souza D; Nascimento JM
    Eur Arch Psychiatry Clin Neurosci; 2017 Feb; 267(1):3-17. PubMed ID: 27377417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining the role of microRNAs in psychiatric disorders.
    Issler O; Chen A
    Nat Rev Neurosci; 2015 Apr; 16(4):201-12. PubMed ID: 25790865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic research in psychiatry.
    Taurines R; Dudley E; Grassl J; Warnke A; Gerlach M; Coogan AN; Thome J
    J Psychopharmacol; 2011 Feb; 25(2):151-96. PubMed ID: 20142298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The need for phosphoproteomic approaches in psychiatric research.
    Martins-de-Souza D; Guest PC; Vanattou-Saifoudine N; Wesseling H; Rahmoune H; Bahn S
    J Psychiatr Res; 2011 Oct; 45(10):1404-6. PubMed ID: 21616503
    [No Abstract]   [Full Text] [Related]  

  • 15. Synaptic proteomics as a means to identify the molecular basis of mental illness: Are we getting there?
    Reig-Viader R; Sindreu C; Bayés À
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt B):353-361. PubMed ID: 28941771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining Patient-Reprogrammed Neural Cells and Proteomics as a Model to Study Psychiatric Disorders.
    Zuccoli GS; Martins-de-Souza D; Guest PC; Rehen SK; Nascimento JM
    Adv Exp Med Biol; 2017; 974():279-287. PubMed ID: 28353247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC-MS
    Fioramonte M; Guest PC; Martins-de-Souza D
    Adv Exp Med Biol; 2017; 974():115-129. PubMed ID: 28353228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All about DIGE: quantification technology for differential-display 2D-gel proteomics.
    Lilley KS; Friedman DB
    Expert Rev Proteomics; 2004 Dec; 1(4):401-9. PubMed ID: 15966837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of proteomics to diagnosis and treatment of lung cancer].
    Dai M; Luo RC
    Ai Zheng; 2007 Jun; 26(6):669-72. PubMed ID: 17562279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and application of proteomics technologies in Saccharomyces cerevisiae.
    Kolkman A; Slijper M; Heck AJ
    Trends Biotechnol; 2005 Dec; 23(12):598-604. PubMed ID: 16202464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.